Reply to 'Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis'.
about
The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expressionClinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia.Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives.Transcription factor mutations in myelodysplastic/myeloproliferative neoplasmsOverexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafishOverexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis.CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemia.
P2860
Q34649120-B60E325C-83DC-48A3-9548-9E19AC119299Q35203340-B2D61A5F-7169-4411-B6C1-6E24BAE62033Q37624593-1561BFBC-7D3A-48E4-87EA-45A7018167D0Q37712353-813354CD-15C6-47BB-B693-8E13457A69ABQ38344558-DC67F20B-8D5F-4857-937C-124DB0CDB9F1Q41177054-5F705F9F-39C6-4653-A018-87BE214198C2Q42113668-9F762238-1722-4A54-90A6-AFE9FB8E7BC5Q43466307-F5F86911-2AC4-49AD-9C92-6C9646A743D9Q48343112-6A54FAE7-8D23-457A-8262-313627C3AAD2
P2860
Reply to 'Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis'.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Reply to 'Heterogeneity within ...... ted with favorable prognosis'.
@en
Reply to 'Heterogeneity within ...... ted with favorable prognosis'.
@nl
type
label
Reply to 'Heterogeneity within ...... ted with favorable prognosis'.
@en
Reply to 'Heterogeneity within ...... ted with favorable prognosis'.
@nl
prefLabel
Reply to 'Heterogeneity within ...... ted with favorable prognosis'.
@en
Reply to 'Heterogeneity within ...... ted with favorable prognosis'.
@nl
P2860
P50
P356
P1476
Reply to 'Heterogeneity within ...... ated with favorable prognosis'
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605207
P407
P577
2009-07-21T00:00:00Z